Diego Kyburz

11.5k total citations · 1 hit paper
125 papers, 6.2k citations indexed

About

Diego Kyburz is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Diego Kyburz has authored 125 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Rheumatology, 54 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in Diego Kyburz's work include Rheumatoid Arthritis Research and Therapies (49 papers), Systemic Lupus Erythematosus Research (23 papers) and Spondyloarthritis Studies and Treatments (20 papers). Diego Kyburz is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (49 papers), Systemic Lupus Erythematosus Research (23 papers) and Spondyloarthritis Studies and Treatments (20 papers). Diego Kyburz collaborates with scholars based in Switzerland, Germany and United States. Diego Kyburz's co-authors include Steffen Gay, Fabia Brentano, Renate E. Gay, Joanna Stańczyk, Christoph Kolling, Caroline Ospelt, Olivier Schorr, Axel Finckh, Michael Detmar and Cem Gabay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Diego Kyburz

117 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis

2008 718 citations Fabia Brentano, Renate E. Gay et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego Kyburz Switzerland	42	2.5k	2.2k	1.7k	1.1k	797	125	6.2k
Shingo Nakayamada Japan	42	2.8k 1.1×	2.5k 1.1×	1.3k 0.7×	361 0.3×	1.1k 1.4×	219	6.3k
Timothy R. D. J. Radstake Netherlands	39	2.5k 1.0×	1.5k 0.7×	1.3k 0.7×	345 0.3×	669 0.8×	174	5.4k
Shigeru Kotake Japan	29	1.8k 0.7×	1.9k 0.9×	2.7k 1.5×	630 0.6×	1.7k 2.1×	111	5.6k
Anca I. Catrina Sweden	49	2.5k 1.0×	4.6k 2.1×	2.1k 1.2×	705 0.6×	1.3k 1.6×	135	9.1k
Yves Renaudineau France	41	2.2k 0.9×	1.8k 0.8×	1.0k 0.6×	330 0.3×	453 0.6×	230	5.4k
Péter Szodoray Hungary	43	2.1k 0.8×	1.9k 0.8×	894 0.5×	315 0.3×	454 0.6×	153	5.6k
Benjamín Fernández‐Gutiérrez Spain	36	1.2k 0.5×	2.4k 1.1×	926 0.5×	416 0.4×	505 0.6×	194	4.9k
A E Koch United States	33	2.7k 1.0×	1.7k 0.7×	1.5k 0.9×	694 0.6×	2.4k 3.0×	47	6.5k
Elisabeth Brouwer Netherlands	50	2.5k 1.0×	4.6k 2.1×	1.2k 0.7×	440 0.4×	547 0.7×	240	9.4k
Monique M. Helsen Netherlands	30	1.9k 0.7×	1.8k 0.8×	1.6k 0.9×	436 0.4×	977 1.2×	50	4.4k

Countries citing papers authored by Diego Kyburz

Since Specialization

Citations

This map shows the geographic impact of Diego Kyburz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Kyburz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Kyburz more than expected).

Fields of papers citing papers by Diego Kyburz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Kyburz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Kyburz. The network helps show where Diego Kyburz may publish in the future.

Co-authorship network of co-authors of Diego Kyburz

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Kyburz. A scholar is included among the top collaborators of Diego Kyburz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Kyburz. Diego Kyburz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Buttgereit, Frank, Thomas Daikeler, Christina Duftner, et al.. (2025). Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica. Lara D. Veeken. 65(2).

2.

Kyburz, Diego, et al.. (2024). Risankizumab and Certolizumab Pegol Dual-Targeted Therapy for Crohn’s Disease and Axial Spondyloarthritis: A Case Report. Case Reports in Gastroenterology. 19(1). 22–30.

3.

Rottenburger, Christof, Markus Aschwanden, Diego Kyburz, et al.. (2024). Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study. Seminars in Arthritis and Rheumatism. 66. 152425–152425. 9 indexed citations

4.

Schulz, Martin, et al.. (2024). Does the Change of Weather Influence Disease Activity in Rheumatoid Arthritis Patients: Patients’ Self-Assessment via WebApp. Journal of Clinical Medicine. 13(17). 5336–5336. 1 indexed citations

5.

Lehmann, Julia, Stavros Giaglis, Diego Kyburz, Douglas Daoudlarian, & U.A. Walker. (2024). POS1206 ORIGIN AND DIAGNOSTIC POTENTIAL OF EXTRACELLULAR DNA IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 83. 740–740.

6.

Riek, Myriam, Almut Scherer, Burkhard Möller, et al.. (2023). Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Scientific Reports. 13(1). 17776–17776. 2 indexed citations

7.

Giaglis, Stavros, Douglas Daoudlarian, Jens Thiel, et al.. (2023). Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides. Lara D. Veeken. 62(8). 2930–2937. 5 indexed citations

8.

Micheroli, Raphael, Kristina Bürki, Burkhard Möller, et al.. (2023). Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clinical Rheumatology. 42(9). 2377–2385. 5 indexed citations

9.

Aschwanden, Markus, Christoph T. Berger, Diego Kyburz, et al.. (2023). Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis. Lara D. Veeken. 63(6). 1523–1527. 2 indexed citations

10.

Micheroli, Raphael, Sangeeta Bhatia, Andrea M. Burden, et al.. (2023). Obesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients. The Journal of Rheumatology. 50(12). 1587–1593. 2 indexed citations

11.

Aschwanden, Markus, Sabine Seiler, Christoph T. Berger, et al.. (2023). Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study. RMD Open. 9(1). e002866–e002866. 8 indexed citations

12.

Scherer, Almut, Andrea Rubbert‐Roth, Axel Finckh, et al.. (2022). Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. Lara D. Veeken. 62(1). 89–97. 21 indexed citations

13.

Giaglis, Stavros, Douglas Daoudlarian, Reinhard Voll, et al.. (2021). Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus. RMD Open. 7(3). e002010–e002010. 19 indexed citations

14.

Gilbert, Benoît, Céline Lamacchia, Denis Mongin, et al.. (2021). Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis. BMJ Open. 11(7). e048409–e048409. 18 indexed citations

15.

Williams, Ross D., et al.. (2021). Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients. Rheumatology Advances in Practice. 5(3). rkab087–rkab087. 4 indexed citations

16.

Boehncke, Wolf‐Henning, Mark Anliker, Curdin Conrad, et al.. (2015). The Dermatologists' Role in Managing Psoriatic Arthritis: Results of a Swiss Delphi Exercise Intended to Improve Collaboration with Rheumatologists. Dermatology. 230(1). 75–81. 13 indexed citations

17.

Pierer, Matthias, et al.. (2009). Herpesvirus Entry Mediator-Ig Treatment during Immunization Aggravates Rheumatoid Arthritis in the Collagen-Induced Arthritis Model. The Journal of Immunology. 182(5). 3139–3145. 31 indexed citations

18.

Pierer, Matthias, Janine Rethage, Reinhart Seibl, et al.. (2004). Chemokine Secretion of Rheumatoid Arthritis Synovial Fibroblasts Stimulated by Toll-Like Receptor 2 Ligands. The Journal of Immunology. 172(2). 1256–1265. 213 indexed citations

19.

Pierer, Matthias, Janine Rethage, Reinhart Seibl, et al.. (2004). Chemokine Secretion of Rheumatoid Arthritis Synovial Fibroblasts Stimulated by Toll-Like Receptor 2 Ligands. The Journal of Immunology. 172(4). 2704–2704. 21 indexed citations

20.

Martinic, Marianne M., Thomas Rülicke, Alana Althage, et al.. (2003). Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC. Proceedings of the National Academy of Sciences. 100(4). 1861–1866. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact